Early vs delayed opioid administration for pediatric sickle cell vaso-occlusive crisis: A systematic review and meta-analysis.
Ayesha Khalid, Alexandra Salazar Riaño, Jonathan D Mohnkern et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated early versus delayed opioid administration in pediatric patients with sickle cell vaso-occlusive episodes (VOE). Analyzing six studies with 3367 patients, the findings indicated no significant differences in hospital admission rates, ED discharge, ED length of stay, or pain reassessment between the two groups. The risk ratio for hospital admission was 0.96 (95% CI 0.85 to 1.10).
Key findings
- No significant difference in hospital admission rates: RR 0.96 (95% CI 0.85 to 1.10).
- ED discharge rates were similar: RR 1.04 (95% CI 0.89 to 1.22).
- ED length of stay showed no significant difference: MD -6.02 min (95% CI -1.22 to 45 to 110.42).
- Pain reassessment scores were comparable: SMD 0.85 (95% CI -1.92 to 3.63).
Why it matters
Understanding the timing of opioid administration in pediatric sickle cell VOE is crucial for optimizing pain management strategies. This study provides evidence that early administration may not confer significant advantages over delayed administration, informing clinical decision-making in emergency settings.